SCHEMBL7468623

SCHEMBL7468623

Cc1nc2c(Cc3c(F)cccc3F)cccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 2/20 0.43
▸ MGAM O43451 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ SI P14410 3/20 0.41
▸ MGAM2 Q2M2H8 3/20 0.41
▸ MPO P05164 1/20 0.41
▸ ADRB2 P07550 1/20 0.38
▸ SMN1; SMN2 Q16637 5/20 0.38
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ NFKB1 P19838 2/20 0.38
▸ NFKB2 Q00653 2/20 0.38
▸ RELA Q04206 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TP53 P04637 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD4 P21917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7468191 0.83 NPC1 (0.43) MGAMGAASIMGAM2MPO
SCHEMBL7471192 0.81 DHODH (0.45) PARP1MGAMGAASIMGAM2
SCHEMBL29438962 0.80 PARP1 (0.53) PARP1MGAMGAASIMGAM2
SCHEMBL1902643 0.80 PARP1 (0.53) PARP1MGAMGAASIMGAM2
SCHEMBL7464867 0.80 MGAM (0.64) PARP1MGAMGAASIMGAM2
SCHEMBL7461763 0.78 GRIN2B (0.54) PARP1MGAMGAASIMGAM2
SCHEMBL6697342 0.78 DRD2 (0.50) PARP1GAAALDH1A1DRD2DRD4
SCHEMBL5280975 0.77 HPGD (0.39) MPOSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL5788740 0.77 PARP1 (0.54) PARP1ADRB2ALDH1A1DRD2DRD4
SCHEMBL8263596 0.77 PARP1 (0.54) PARP1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210336-A1 SUBSTITUTED BENZIMIDAZOLES AS NON-NUCLEOSIDE INHIBITORS OF REVERSE TRANSCRIPTASE THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services (US) 2002-06-05 — — EP disclosed
WO-2001014343-A1 SUBSTITUTED BENZIMIDAZOLES AS NON-NUCLEOSIDE INHIBITORS OF REVERSE TRANSCRIPTASE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2001-03-01 — — WO disclosed
EP-0963371-A1 SUBSTITUTED BENZIMIDAZOLES AS NON-NUCLEOSIDE INHIBITORS OF REVERSE TRANSCRIPTASE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-15 — — EP disclosed
WO-1998037072-A1 SUBSTITUTED BENZIMIDAZOLES AS NON-NUCLEOSIDE INHIBITORS OF REVERSE TRANSCRIPTASE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-08-27 — — WO disclosed
Send feedback